59 /100
MEDIUM RISK
Score updated Feb 26, 2026
LYEL
Lyell Immunopharma, Inc.

DilutionScore™ measures dilution risk across 5 factors. Lower scores indicate higher risk of share dilution.

🔔 Get alerts when LYEL's score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
100
📊 Float Risk
60
⚠️ Warrant Exposure
85
🔄Convertible Debt
💹 Market Data
Market Cap$509.85M
Shares Outstanding21.24M
Float10.57M
Cash$319.62M
Debt$44.28M
Short InterestN/A
🏛 Institutional Holdings
57 institutional holders · 10.23M shares
#1 ARCH Venture Management, LLC 2.76M shares
#2 Almitas Capital LLC 1.16M shares
#3 MWG Management Ltd. 1.01M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest407.3K
Days to Cover4.0
% of Float3.9%
FINRA data as of Jan 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account
📰 Recent News
Track LYEL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LYEL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required